24/7 Clients Support
- 24/7
Customer Service
- ISO 9001
Certification Company
- WHO-GMP
Certified Company
PACLIEVA 300MG is an Injection medication used for treatment purposes. It is manufactured by Allieva Pharma Private Limited.
| Brand Name | PACLIEVA 300MG |
|---|---|
| Composition | Paclitaxel Injection 300mg |
| Manufacturer | Allieva Pharma Private Limited |
| Dosage Form | Injection |
| Packaging | Vial |
| Country of Origin | India |
Paclitaxel Injection 300mg (Paclitaxel Injection 300mg) is a widely used Injection medicine manufactured by Allieva Pharma Private Limited. It is commonly prescribed for...
Paclieva 300 mg contains Paclitaxel, a chemotherapy (anticancer) drug belonging to the taxane class. It works by stabilizing microtubules and preventing their depolymerization, which inhibits mitosis and leads to death of rapidly dividing cancer cells.
Paclitaxel Injection is used in the treatment of:
Breast cancer
Ovarian cancer
Non-small cell lung cancer (NSCLC)
AIDS-related Kaposi’s sarcoma
Head and neck cancers (in combination chemotherapy)
Common side effects:
Hair loss (alopecia)
Nausea, vomiting
Myelosuppression (neutropenia, anemia, thrombocytopenia)
Fatigue and weakness
Muscle and joint pain
Peripheral neuropathy (tingling, numbness)
Dosage is based on body surface area (BSA), type of cancer, and treatment protocol.
Common regimens:
175 mg/m² IV infusion over 3 hours every 3 weeks
135 mg/m² IV infusion over 24 hours every 3 weeks
Weekly schedule: 80–100 mg/m² IV
NOTE: This medicine should be taken only under a doctor’s supervision.